Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment.

CONCLUSION: Perceptions about medication and the communication style with, and trust in, the rheumatologist were mentioned the most in relation to starting DMARD. The rheumatologist plays a crucial role in influencing adherence behavior by addressing perceptions about medication, providing information, and establishing trust in the treatment plan.
PMID: 25512473 [PubMed - as supplied by publisher]

Source: J Rheumatol - December 15, 2014 Category: Rheumatology Authors: Pasma A, Van't Spijker A, Luime JJ, Walter MJ, Busschbach JJ, Hazes JM Tags: J Rheumatol Source Type: research